Asia Pacific pain management devices will grow by 9.7% annually with a total addressable market cap of $16,238.7 million over 2022-2031, driven by the growing demand for chronic pain management among the geriatric population, the increasing availability of technically advanced pain management devices, supportive reimbursement policies and adverse effects of pain medications, and the growing awareness of pain management devices.
Highlighted with 33 tables and 47 figures, this 100-page report “Asia Pacific Pain Management Devices Market 2021-2031 by Product (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps, Ablation Devices), Application (Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain, Others), Mode of Purchase (Prescription, OTC), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific pain management devices market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific pain management devices market in every aspect of the classification from perspectives of Product, Application, Mode of Purchase, and Country.
Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Neuromodulation & Neurostimulation Devices
o Spinal Cord Stimulators
o Transcutaneous Electrical Nerve Stimulation (TENS) Devices
o Sacral Nerve Stimulators
o Deep Brain Stimulators
o Other Neuromodulation & Neurostimulation Devices
• Analgesic Infusion Pumps
o External Infusion Pumps
o Intrathecal Infusion Pumps
• Ablation Devices
o Radiofrequency Ablation Devices
o Cryoablation Devices
Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Neuropathic Pain
• Musculoskeletal Pain
• Cancer Pain
• Facial & Migraine Pain
• Other Applications
By Mode of Purchase, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Prescription
• Over-the-counter (OTC)
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Application and Mode of Purchase over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
B. Braun Melsungen AG
Baxter International Inc.
Becton, Dickinson and Company
Boston Scientific Corp.
Colfax Corporation (DJO Global LLC)
Johnson & Johnson (Codman and Shurtleff, Inc.)
Kimberly Clark Corporation
Medtronic Plc.
Nevro Corp
Pfizer, Inc.
Smiths Medical, Inc.
Stryker Corp.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 12
1.2.6 Market Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15
2 Market Overview and Dynamics 17
2.1 Market Size and Forecast 17
2.1.1 Impact of COVID-19 on World Economy 18
2.1.2 Impact of COVID-19 on the Market 20
2.2 Major Growth Drivers 22
2.3 Market Restraints and Challenges 28
2.4 Emerging Opportunities and Market Trends 31
2.5 Porter’s Fiver Forces Analysis 35
3 Segmentation of Asia Pacific Market by Product 39
3.1 Market Overview by Product 39
3.2 Neuromodulation & Neurostimulation Devices 41
3.2.1 Spinal Cord Stimulators 43
3.2.2 Transcutaneous Electrical Nerve Stimulation (TENS) Devices 44
3.2.3 Sacral Nerve Stimulators 45
3.2.4 Deep Brain Stimulators 46
3.2.5 Other Neuromodulation & Neurostimulation Devices 47
3.3 Analgesic Infusion Pumps 48
3.3.1 External Infusion Pumps 49
3.3.2 Intrathecal Infusion Pumps 50
3.4 Ablation Devices 51
3.4.1 Radiofrequency Ablation Devices 52
3.4.2 Cryoablation Devices 53
4 Segmentation of Asia Pacific Market by Application 54
4.1 Market Overview by Application 54
4.2 Neuropathic Pain 56
4.3 Musculoskeletal Pain 57
4.4 Cancer Pain 58
4.5 Facial & Migraine Pain 59
4.6 Other Applications 60
5 Segmentation of Asia Pacific Market by Mode of Purchase 61
5.1 Market Overview by Mode of Purchase 61
5.2 Prescription 63
5.3 Over-the-counter (OTC) 64
6 Asia-Pacific Market 2021-2031 by Country 65
6.1 Overview of Asia-Pacific Market 65
6.2 Japan 68
6.3 China 71
6.4 Australia 73
6.5 India 75
6.6 South Korea 77
6.7 Rest of APAC Region 79
7 Competitive Landscape 81
7.1 Overview of Key Vendors 81
7.2 New Product Launch, Partnership, Investment, and M&A 84
7.3 Company Profiles 85
Abbott Laboratories 85
B. Braun Melsungen AG 87
Baxter International Inc. 88
Becton, Dickinson and Company 89
Boston Scientific Corp. 90
Colfax Corporation (DJO Global LLC) 91
Johnson & Johnson (Codman and Shurtleff, Inc.) 92
Kimberly Clark Corporation 93
Medtronic Plc. 94
Nevro Corp 95
Pfizer, Inc. 96
Smiths Medical, Inc. 97
Stryker Corp. 98
RELATED REPORTS 99
List of Tables:
Table 1. Snapshot of Asia Pacific Pain Management Devices Market in Balanced Perspective, 2021-2031 16
Table 2. World Economic Outlook, 2021-2031 19
Table 3. World Health Spending by Region, $ bn, 2013-2020 27
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Pain Management Devices Market 31
Table 5. Asia Pacific Pain Management Devices Market by Product, 2021-2031, $ mn 39
Table 6. Asia Pacific Pain Management Devices Market: Neuromodulation & Neurostimulation Devices by Type, 2021-2031, $ mn 42
Table 7. Asia Pacific Pain Management Devices Market: Analgesic Infusion Pumps by Type, 2021-2031, $ mn 48
Table 8. Asia Pacific Pain Management Devices Market: Ablation Devices by Type, 2021-2031, $ mn 51
Table 9. Asia Pacific Pain Management Devices Market by Application, 2021-2031, $ mn 54
Table 10. Asia Pacific Pain Management Devices Market by Mode of Purchase, 2021-2031, $ mn 61
Table 11. APAC Pain Management Devices Market by Country, 2021-2031, $ mn 66
Table 12. Japan Pain Management Devices Market by Product, 2021-2031, $ mn 70
Table 13. Japan Pain Management Devices Market by Application, 2021-2031, $ mn 70
Table 14. Japan Pain Management Devices Market by Mode of Purchase, 2021-2031, $ mn 70
Table 15. China Pain Management Devices Market by Product, 2021-2031, $ mn 72
Table 16. China Pain Management Devices Market by Application, 2021-2031, $ mn 72
Table 17. China Pain Management Devices Market by Mode of Purchase, 2021-2031, $ mn 72
Table 18. Australia Pain Management Devices Market by Product, 2021-2031, $ mn 74
Table 19. Australia Pain Management Devices Market by Application, 2021-2031, $ mn 74
Table 20. Australia Pain Management Devices Market by Mode of Purchase, 2021-2031, $ mn 74
Table 21. India Pain Management Devices Market by Product, 2021-2031, $ mn 76
Table 22. India Pain Management Devices Market by Application, 2021-2031, $ mn 76
Table 23. India Pain Management Devices Market by Mode of Purchase, 2021-2031, $ mn 76
Table 24. South Korea Pain Management Devices Market by Product, 2021-2031, $ mn 78
Table 25. South Korea Pain Management Devices Market by Application, 2021-2031, $ mn 78
Table 26. South Korea Pain Management Devices Market by Mode of Purchase, 2021-2031, $ mn 78
Table 27. Pain Management Devices Market in Rest of APAC by Country/Region, 2021-2031, $ mn 80
Table 28. Abbott Laboratories: Company Snapshot 85
Table 29. Abbott Laboratories: Business Segmentation 86
Table 30. Abbott Laboratories: Product Portfolio 86
